Apimeds Pharmaceuticals US, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Matawan, NJ
SEC filing record 1 source field available
Fiscal year end
31 December
Apimeds Pharmaceuticals US, Inc. has filed 118 SEC EDGAR filings since 29 Jan 2024

SEC filing history

Showing 1-3 of 3 matching filings.

Per page
25
Current page
1
10-K File 001-42545

ANNUAL REPORT

Filing date
04 May 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
10-K/A File 001-42545

AMENDMENT NO. 1 TO FORM 10-K

Filing date
02 May 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
10-K File 001-42545

ANNUAL REPORT

Filing date
15 Apr 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .